Latus Bio, Inc. (Latus) a biotechnology company engineering gene therapies at scale, today announced that P. Peter Ghoroghchian, M.D., Ph.D., Chief Executive Officer of Latus Bio, will participate in a fireside chat at Chardan’s 10^th Annual Healthcare Conference, taking place on October 20, 2026 in New York City at 2:45 p.m. ET. Registered investors attending the conference will have the opportunity to meet directly with members of the management team through scheduled one-on-one sessions. To request a meeting with the management team, please contact your Chardan salesperson.

About Latus Bio

Latus is a biotechnology company dedicated to addressing devastating CNS and peripheral diseases via innovative and scalable gene therapies. The Company is advancing a broad therapeutics pipeline based on novel AAV capsid variants with potency and specificity. Latus is powered by a diverse team of visionary scientists, experienced clinicians, and leading industry executives. The Company has offices in Philadelphia, PA and in the Seaport in Boston, MA. For more information, visit www.latusbio.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20261015167766/en/